Revisited and large-scale synthesis and purification of the mutated and wild type neu/erbB-2 membrane-spanning segment

被引:9
作者
Khemtemourian, Lucie [1 ]
Lavielle, Sebastien [1 ]
Bathany, Katell [1 ]
Schmitter, Jean-Marie [1 ]
Dufourc, Erick J. [1 ]
机构
[1] Univ Bordeaux 1, CNRS, UMR 5144, MOBIOS,IECB, F-33607 Pessac, France
关键词
solid-phase synthesis; hydrophobic peptide; reversed-phase HPLC; MALDI-ToF mass spectrometry; N-15-labelled amino acids; circular dichroism; alpha-helices;
D O I
10.1002/psc.735
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solid-phase syntheses of the hydrophobic peptides Neu(TM35) ((1)EQRASPVTFIIATVVGVLLFLILVVVVGILIKRRR(35)) and Neu*(TM35) ((1)EQRASPVTFIIATVEGVLLFLILVVVVGILIKRRR(35)), corresponding to the native and mutated (V15E) transmembrane domain of the neu/erbB-2 tyrosine kinase receptor, respectively, were accomplished using Fmoc chemistry. The use of a new resin and cleavage and purification conditions led to large increases in yields and peptide purity. Two N-15-labelled versions of both wild type and mutated peptides were also synthesized. Approximately 20-40 mg of peptide was obtained using a small-scale synthesis, whereas ca 100 mg of pure peptide was collected on a medium scale. Peptide purity, as monitored by HPLC and mass spectrometry, ranged from 95 to 98% for the six peptides synthesized. Secondary structure as determined by UV circular dichroism (CD) in trifluoroethanol (TFE) showed ca 74% alpha-helical content: for the native peptide and ca 63% for that bearing the mutation. Secondary structure of NeuTM35 was retained in DMPC (dimyristoylphosphatidylcholine)/DCPC (dicaproylphosphatidylcholine) membrane bicelles, and evidences for dimers/oligomers in the lipid bilayer were found. Copyright (c) 2005 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 25 条
[11]   Purification of the c-erbB2/neu membrane-spanning segment:: a hydrophobic challenge [J].
Goetz, M ;
Rusconi, F ;
Belghazi, M ;
Schmitter, JM ;
Dufourc, EJ .
JOURNAL OF CHROMATOGRAPHY B, 2000, 737 (1-2) :55-61
[12]  
Grant G. A., 1992, SYNTHETIC PEPTIDES U
[13]   Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE [J].
Houliston, RS ;
Hodges, RS ;
Sharom, FJ ;
Davis, JH .
FEBS LETTERS, 2003, 535 (1-3) :39-43
[14]   Oligomerization of the EGF receptor transmembrane domain: A H-2 NMR study in lipid bilayers [J].
Jones, DH ;
Rigby, AC ;
Barber, KR ;
Grant, CWM .
BIOCHEMISTRY, 1997, 36 (41) :12616-12624
[15]  
LAU SYM, 1984, J BIOL CHEM, V259, P3253
[16]   Bicelle membranes and their use for hydrophobic peptide studies by circular dichroism and solid state NMR [J].
Loudet, U ;
Khemtémourian, L ;
Aussenac, F ;
Gineste, S ;
Achard, MF ;
Dufourc, EJ .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1724 (03) :315-323
[17]   Synthesis and purification of amyloidogenic peptides [J].
Nilsson, MR ;
Nguyen, LL ;
Raleigh, DP .
ANALYTICAL BIOCHEMISTRY, 2001, 288 (01) :76-82
[18]   Temperature-composition diagram of dimyristoylphosphatidylcholine-dicaproylphosphatidylcholine "bicelles" self-orienting in the magnetic field.: A solid state 2H and 31P NMR study [J].
Raffard, G ;
Steinbruckner, S ;
Arnold, A ;
Davis, JH ;
Dufourc, EJ .
LANGMUIR, 2000, 16 (20) :7655-7662
[19]   Transmembrane region of the epidermal growth factor receptor: Behavior and interactions via H-2 NMR [J].
Rigby, AC ;
Barber, KR ;
Shaw, GS ;
Grant, CWM .
BIOCHEMISTRY, 1996, 35 (38) :12591-12601
[20]  
Rusconi F, 1998, ANALUSIS, V26, pM13